Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Elanco Animal Health Inc (ELAN) NPV

Sell:$31.67 Buy:$31.73 Change: $0.18 (0.57%)
Market closed |  Prices as at close on 25 February 2021 | Switch to live prices |
Sell:$31.67
Buy:$31.73
Change: $0.18 (0.57%)
Market closed |  Prices as at close on 25 February 2021 | Switch to live prices |
Sell:$31.67
Buy:$31.73
Change: $0.18 (0.57%)
Market closed |  Prices as at close on 25 February 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Elanco Animal Health Incorporated is an animal health company that develops, manufactures and markets products for companion and food animals. The Company offers its products under four primary categories, such as Companion Animal Disease Prevention, Companion Animal Therapeutics, Food Animal Future Protein & Health, and Food Animal Ruminants & Swine. It provides a range of parasiticide portfolios in the companion animal sector based on indications, species and formulations, with products that protect pets from worms, fleas and ticks. It also offers a pain and osteoarthritis portfolio across species, modes of action, indications and disease stages. It also provides treatments for otitis (ear infections), as well as cardiovascular and dermatology indications. Its portfolio in Food Animal Future Protein & Health category includes vaccines, nutritional enzymes and animal-only antibiotics. It also provides products in poultry and aquaculture production.

Contact details

Address:
2500 Innovation Way N
GREENFIELD
46140-9163
United States
Telephone:
+ ()
Website:
https://www.elanco.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
ELAN
ISIN:
US28414H1032
Market cap:
$14.89 billion
Shares in issue:
471.92 million
Sector:
Pharmaceuticals
Exchange:
New York Stock Exchange
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • R. David Hoover
    Independent Chairman of the Board
  • Jeffrey Simmons
    President, Chief Executive Officer, Director
  • Todd Young
    Chief Financial Officer, Executive Vice President
  • David Kinard
    Executive Vice President of Human Resources
  • Sarena Lin
    Executive Vice President, Global Marketing, Corporate Strategy and Transformation
  • Ramiro Cabral
    Executive Vice President - Elanco International
  • Aaron Schacht
    Executive Vice President - Innovation, Regulatory, Business Development
  • David Urbanek
    Executive Vice President - Manufacturing, Quality
  • James Meer
    Chief Accounting Officer, Vice President

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.